Symposium : Stroma immunity and cancer

We are pleased to announce the upcoming Symposium on STROMA, IMMUNITY, and CANCER, to be held on Tuesday, June 23rd, 2026, at the Institut Curie (Constant Burg Auditorium, Institut Curie, 12 rue Lhomond, 75005 Paris).

This one-day event will focus on both fundamental and applied research in the rapidly expanding field of stromal (particularly fibroblasts and endothelial cells) and immune cell interactions within the tumor microenvironment (TME).

Over the past decade, the tumor stroma has emerged as a promising therapeutic target in cancer, with cancer-associated fibroblasts (CAFs) playing a key role in shaping the TME, regulating tumor growth, promoting immune evasion, and contributing to resistance to chemotherapy and immunotherapy.

KEYNOTE SPEAKERS : Alexandra Naba - Univ. Illinois USA & Shannon Turley - Amgen USA

SPEAKERS: Corinne Bousquet - CRCT Toulouse ; Cédric Gaggioli - IRCAN Nice ; Matthew Krummel - UCSF USA ; Fatima Mechta-Grigoriou - IC Paris ; Lucie Peduto - I. Pasteur Paris; Hélène Salmon - IC Paris ; Karine Tarte - Univ. Rennes ; Danijela Vignjevic - IC Paris

In addition to these speakers, three young postdocs/researchers will be selected to give short presentations (10 minutes + 5 minutes for questions). Selection will be based on poster abstracts submitted during registration.

We will widely disseminate the symposium announcement to maximize visibility and attract international academic or industrial researchers, students, physicians, and engineers, who will be responsible for their own travel and accommodation expenses.

A poster session with a diner cocktail will be held at the end of the symposium, but posters will be displayed starting in the morning near the coffee/lunch area to encourage exchanges during all breaks.

The Women’s Cancer Institute IHU and the SIRIC of the Institut Curie, La Ligue contre le Cancer, the ARC Foundation, Sanofi, Olink and Sartorius are sponsoring the event. We thank them warmly.